Not applicableWithdrawnNCT02306512What this trial is testingMohs and Immunofluorescence for Malignant Melanoma In SituWho this might be right forLentigo MalignaMelanoma In Situ University of Miami
Not applicableEnrolling By InvitationNCT06388252What this trial is testingElectrochemotherapy Induces Changes in the Tumor Microenvironment of Cutaneous and Subcutaneous Metastases in Patients With Cutaneous MelanomaWho this might be right forCutaneous Malignant Melanoma Institute of Oncology Ljubljana 10
Not applicableStudy completedNCT04476082What this trial is testingNutrition in Gastrointestinal TumorsWho this might be right forPancreatic CancerOesophageal CancerColon Cancer+7 more University Medicine Greifswald 66
Early research (Phase 1)Study completedNCT01107418What this trial is testingA Pharmacokinetic/Pharmacodynamic Study of RO5185426 in Previously Treated Patients With Metastatic MelanomaWho this might be right forMalignant Melanoma Hoffmann-La Roche 52
Testing effectiveness (Phase 2)Study completedNCT00350597What this trial is testingGM-CSF as Adjuvant Therapy of MelanomaWho this might be right forMalignant Melanoma Northern California Melanoma Center 50
Not applicableStudy completedNCT02129049What this trial is testingTelephone-Based Educational Intervention in Improving Communication Between Patients With Stage 0-III Cancer and Their ChildrenWho this might be right forBreast CancerCervical CancerColon Cancer+5 more University of Washington 35
Early research (Phase 1)Study completedNCT03084640What this trial is testingPhase 1B Study Evaluating Alternative Routes of Administration of CMP-001 in Combination With Pembrolizumab in Participants With Advanced MelanomaWho this might be right forMalignant Melanoma Regeneron Pharmaceuticals 30
Early research (Phase 1)Looking for participantsNCT04038619What this trial is testingFecal Microbiota Transplantation in Treating Immune-Checkpoint Inhibitor Induced-Diarrhea or Colitis in Genitourinary Cancer PatientsWho this might be right forColitisDiarrheaMalignant Genitourinary System Neoplasm+6 more M.D. Anderson Cancer Center 40
Testing effectiveness (Phase 2)Active Not RecruitingNCT04083599What this trial is testingGEN1042 Safety Trial and Anti-tumor Activity in Participants With Malignant Solid TumorsWho this might be right forMalignant Solid TumorNon-Small Cell Lung Cancer (NSCLC)Colorectal Cancer (CRC)+3 more Genmab 350
Not applicableLooking for participantsNCT07072143What this trial is testingAn International Study on Pediatric Patients With Rare Tumors.Who this might be right forParaganglioma/ PhaeochromocytomaMelanoma and Other Malignant Neoplasms of SkinGastrointestinal Stromal Tumor (GIST)+11 more Azienda Ospedaliera di Padova 6,250
Testing effectiveness (Phase 2)Ended earlyNCT05551117What this trial is testingVobramitamab Duocarmazine in Participants With Metastatic Castration Resistant Prostate Cancer and Other Solid TumorsWho this might be right forCastration-Resistant Prostatic CancerAndrogen-Independent Prostatic CancerAndrogen-Insensitive Prostatic Cancer+14 more MacroGenics 192
Testing effectiveness (Phase 2)Study completedNCT00041808What this trial is testingMagnetic-Targeted Doxorubicin in Treating Patients With Cancer Metastatic to the LiverWho this might be right forMetastases, NeoplasmColorectal NeoplasmsEsophageal Neoplasms+9 more FeRx 20
Early research (Phase 1)Study completedNCT03158935What this trial is testingThe ACTIVATE (Adoptive Cell Therapy InVigorated to Augment Tumor Eradication) TrialWho this might be right forAdvanced Ovarian CancerMalignant Melanoma University Health Network, Toronto 8
Not applicableUnknownNCT03454282What this trial is testingImpact of Dietary Intervention on Tumor Immunity: the DigesT TrialWho this might be right forBreast CancerMelanoma, Malignant Fondazione IRCCS Istituto Nazionale dei Tumori, Milano 100
Not applicableStudy completedNCT03034395What this trial is testingStudy of 1cm Versus 2cm Margins for the Surgical Treatment of cT2N0M0 MelanomaWho this might be right forMalignant Melanoma University of Kansas Medical Center 15
Early research (Phase 1)Looking for participantsNCT05266612What this trial is testingPhase I Study VG2025 as a Single Agent and in Combination Therapy With Nivolumab in Subjects With Advanced Malignant Solid TumorsWho this might be right forSolid Tumor Virogin Biotech Canada Ltd 12
Not applicableLooking for participantsNCT02828202What this trial is testingFollow-up of a National Cohort of Melanoma Resectable Stage II, Stage III or IV Patients or Unresectable PrimaryWho this might be right forMalignant Melanoma Assistance Publique - Hôpitaux de Paris 6,000
Testing effectiveness (Phase 2)Ended earlyNCT01264081What this trial is testingLapatinib in Stage IV Melanoma With ERBB4 MutationsWho this might be right forMalignant Melanoma National Cancer Institute (NCI) 34
Not applicableUnknownNCT03048253What this trial is testingA Phase I-c Study of Recombinant GM-CSF Herpes Simplex Virus to TreatⅣ M1cWho this might be right forMelanoma OrienGene Biotechnology Ltd. 30
Not applicableEnded earlyNCT03321903What this trial is testingEPR Tumor Oximetry With CE India InkWho this might be right forNeoplasms, MalignantBreast NeoplasmCarcinoma, Basal Cell+4 more Philip Schaner 3